Psychiatry News

Young children in the United States experienced “relatively modest” decreases in developmental scores during the COVID-19 pandemic, according to a study published in JAMA Pediatrics.

In a 3-2 vote, the Federal Trade Commission passed a final rule that bans new noncompete agreements with all workers in for-profit organizations.

DENVER — For those experiencing chronic migraine, the presence of self-reported psychiatric conditions did not affect the effectiveness of eptinezumab, according to a poster at the American Academy of Neurology annual meeting.

Less than optimal heart health at midlife was associated with a decline in the mental processing speed of Black women, but not white women, researchers reported.

ATLANTA — Adults genetically predisposed to high stress are more likely to have a heart attack during times of heightened stress, such as a major holiday or after a presidential election, researchers reported.

The FDA has granted breakthrough device designation to a blood-based biomarker test to more quickly detect amyloid presence in individuals with suspected Alzheimer’s disease, according to the manufacturer.

Therapist burnout was associated with lower odds of clinically meaningful improvement among patients being treated for PTSD, according to a study published in JAMA Network Open.

BOSTON — There is some evidence that cannabinoids may help with neuropathic pain, chemotherapy-induced nausea/vomiting and MS-associated spasticity, “but it’s not exactly a slam dunk,” a speaker said.

Terran Biosciences has been awarded a U.S. patent for the world’s first new salts and polymorphs of MDMA, pharmaceutical compositions using these forms, and the method of use for treatment of PTSD, according to a company press release.

When it comes to work-life balance, providers in the past skewed more toward work than life.